ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Outcomes of Renal Disease Related to Monoclonal Gammopathy After Kidney Transplantation: A Single Center Experience.

T. Kaur, E. Poggio, S. Nurko.

Nephrology, Cleveland Clinic, Cleveland

Meeting: 2017 American Transplant Congress

Abstract number: B142

Keywords: Kidney transplantation, Post-transplant malignancy

Session Information

Session Name: Poster Session B: Kidney Complications II

Session Type: Poster Session

Date: Sunday, April 30, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Kidneys are commonly involved in patients with monoclonal gammopathies (MG). However, the role of kidney transplants (KTx) in MG still needs to be more clearly defined. One review of 8 case reports noted average renal and patient survival of 35 months in patients with multiple myeloma (MM). Another retrospective study of monoclonal immunoglobulin deposition disease (MIDD) reported recurrence in 5/7 patients after KTx. We report our institute's experience with patients with MG diagnosed prior to KTx

We performed a retrospective chart review study on patients in our database with KTx between 01/2001 till 12/2015. Out of total 2890 patients, 115 were found to have MG based on serum or urine immunofixation and ICD 10 code. A manual chart review was done on these 115 patients; 37 patients were identified with MG prior to the KTx and 37 after the KTx.

Results:

Among those 37 patients diagnosed prior to KTx, 23 had MGUS, 13 had kidney disease related to MG and 1 had smoldering myeloma (SM).

Out of these 14 patients, 8 (57 %) had recurrence or progression of the disease and 1 lost to follow-up.

Disease(n) Median Age at KTx (yrs) Gender (n) MG Outcome (n) Time to event after KTx (median)
Myeloma kidney(4) 56 years Female (2)

Male (2)

MM (2)

Stable (2)*

16 months
MIDD (7) 64 years Male (5)

Female (2)

MM(2)

MIDD (1)

Lymphoplasmacytic lymphoma (1)

Proximal tubulopathy (1)

Stable (2)

84 months
MPGN (1) 66 years Male Lost follow up NA
TMA (1) 63 years Male C3 GN 1 week
SM 55 years Male Amyloidosis 90 months

All 14 (100%) patients were alive with functioning graft at 1-year post-KTx, 13/14 (92 %) patients were alive with functioning graft at 3 years. However, in terms of long-term patient and graft survival (Median follow-up 4.7 years, range 1.4-14 years ), 4(28.5 %) patients had stable graft function, 5(35.7 %) had reduced graft function, 1(7 %) was alive with failed graft and 4 were (28 %) deceased.

2 patients without recurrence after KTX had combined autologous stem cell TX and KTx for MM.*

Out 23 patients with MGUS, only 1/23 (4 %) developed proximal tubulopathy.

Conclusion: Patients with MG related kidney disease have a high rate of recurrence and progression after KTx. In addition, they have increased rates of long-term graft dysfunction and poor patient survival. These patients should be carefully counseled and selected before KTx.

CITATION INFORMATION: Kaur T, Poggio E, Nurko S. Outcomes of Renal Disease Related to Monoclonal Gammopathy After Kidney Transplantation: A Single Center Experience. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kaur T, Poggio E, Nurko S. Outcomes of Renal Disease Related to Monoclonal Gammopathy After Kidney Transplantation: A Single Center Experience. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/outcomes-of-renal-disease-related-to-monoclonal-gammopathy-after-kidney-transplantation-a-single-center-experience/. Accessed May 9, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences